Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Appl Phys Lett ; 109(4): 043703, 2016 07 25.
Artigo em Inglês | MEDLINE | ID: mdl-27746482

RESUMO

The structure and connectivity of cultured neuronal networks can be controlled by using micropatterned surfaces. Here, we demonstrate that the direction of signal propagation can be precisely controlled at a single-cell resolution by growing primary neurons on micropatterns. To achieve this, we first examined the process by which axons develop and how synapses form in micropatterned primary neurons using immunocytochemistry. By aligning asymmetric micropatterns with a marginal gap, it was possible to pattern primary neurons with a directed polarization axis at the single-cell level. We then examined how synapses develop on micropatterned hippocampal neurons. Three types of micropatterns with different numbers of short paths for dendrite growth were compared. A normal development in synapse density was observed when micropatterns with three or more short paths were used. Finally, we performed double patch clamp recordings on micropatterned neurons to confirm that these synapses are indeed functional, and that the neuronal signal is transmitted unidirectionally in the intended orientation. This work provides a practical guideline for patterning single neurons to design functional neuronal networks in vitro with the direction of signal propagation being controlled.

2.
Neuroscience ; 151(2): 320-8, 2008 Jan 24.
Artigo em Inglês | MEDLINE | ID: mdl-18083311

RESUMO

Delta(9)-tetrahydrocannabinol (THC) has been reported to induce catalepsy-like immobilization, but the mechanism underlying this effect remains unclear. In the present study, in order to fully understand the neural circuits involved, we determined the brain sites involved in the immobilization effect in rats. THC dose-dependently induced catalepsy-like immobilization. THC-induced catalepsy-like immobilization is mechanistically different from that induced by haloperidol (HPD), because unlike HPD-induced catalepsy, animals with THC-induced catalepsy became normal again following sound and air-puff stimuli. THC-induced catalepsy was reversed by SR141716, a selective cannabinoid CB(1) receptor antagonist. Moreover, THC-induced catalepsy was abolished by lesions in the nucleus accumbens (NAc) and central amygdala (ACE) regions. On the other hand, HPD-induced catalepsy was suppressed by lesions in the caudate putamen (CP), substantia nigra (SN), globus pallidus (GP), ACE and lateral hypothalamus (LH) regions. Bilateral microinjection of THC into the NAc region induced catalepsy-like immobilization. This THC-induced catalepsy was inhibited by serotonergic drugs such as 5-hydroxy-L-tryptophan (5-HTP), a 5-HT precursor, and 5-methoxy-N,N-dimethyltryptamine (5-MeODMT), a 5-HT receptor agonist, as well as by anti-glutamatergic drugs such as MK-801 and amantadine, an N-methyl-d-aspartate (NMDA) receptor antagonist. THC significantly decreased 5-HT and glutamate release in the NAc, as shown by in vivo microdialysis. SR141716 reversed and MK-801 inhibited this decrease in 5-HT and glutamate release. These findings suggest that the THC-induced catalepsy is mechanistically different from HPD-induced catalepsy and that the catalepsy-like immobilization induced by THC is mediated by decreased 5-HT neurotransmission in the nucleus accumbens due to the action of glutamate-containing neurons.


Assuntos
Catalepsia/induzido quimicamente , Dronabinol , Ácido Glutâmico/fisiologia , Alucinógenos , Neurônios/fisiologia , Núcleo Accumbens/metabolismo , Serotonina/fisiologia , Transmissão Sináptica/efeitos dos fármacos , Estimulação Acústica , Amantadina/farmacologia , Animais , Catalepsia/psicologia , Maleato de Dizocilpina/farmacologia , Dopaminérgicos/farmacologia , Antagonistas de Aminoácidos Excitatórios/farmacologia , Espaço Extracelular/efeitos dos fármacos , Espaço Extracelular/metabolismo , Ácido Glutâmico/metabolismo , Masculino , Microinjeções , Neurônios/efeitos dos fármacos , Núcleo Accumbens/efeitos dos fármacos , Estimulação Física , Piperidinas/farmacologia , Pirazóis/farmacologia , Ratos , Ratos Wistar , Receptor CB1 de Canabinoide/antagonistas & inibidores , Receptores de N-Metil-D-Aspartato/antagonistas & inibidores , Rimonabanto , Serotonina/metabolismo , Agonistas do Receptor de Serotonina/farmacologia
3.
Neuropharmacology ; 44(8): 1022-30, 2003 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-12763095

RESUMO

5-HT is known to modify the excitability of GABAergic interneurons projecting to hippocampal CA1 neurons. In this study we investigate the presence and functionally characterize the 5-HT receptor subtypes found on the presynaptic nerve terminals of these GABAergic neurons. Using conventional whole-cell patch recording, we confirmed that the 5-HT(1A) agonist, 8-hydroxy-2-dipropylaminotetralin, presynaptically decreased electrically evoked GABA release while the 5-HT(3) agonist, m-chlorophenylbiguanide (mCPBG), presynaptically facilitated release. Using the 'synaptic bouton preparation', where CA1 neurons are acutely isolated with functional nerve terminals/boutons remaining adherent, we next showed that these receptor subtypes are found presynaptically. We next used the technique of focal stimulation of a single bouton in this preparation to further investigate the distribution of these 5-HT receptor subtypes. We found that all boutons contained inhibitory 5-HT(1A) receptors while a subset of boutons showed both 5-HT(1A) and excitatory 5-HT(3) receptors. No boutons were detected which contained only 5-HT(3) receptors. Our studies show that presynaptic 5-HT receptor subtypes are found presynaptically and are not uniformly distributed. This provides another potential mechanism whereby 5-HT can modulate GABA release and hence the excitability of hippocampal neurons.


Assuntos
Hipocampo/fisiologia , Terminações Pré-Sinápticas/fisiologia , Células Piramidais/fisiologia , Receptores Pré-Sinápticos/fisiologia , Receptores de Serotonina/fisiologia , Animais , Potenciais Evocados , Hipocampo/metabolismo , Hipocampo/ultraestrutura , Técnicas In Vitro , Técnicas de Patch-Clamp , Terminações Pré-Sinápticas/metabolismo , Células Piramidais/metabolismo , Ratos , Ratos Wistar , Receptores Pré-Sinápticos/metabolismo , Receptores de Serotonina/metabolismo , Receptores 5-HT1 de Serotonina , Receptores 5-HT3 de Serotonina , Ácido gama-Aminobutírico/metabolismo
4.
J Physiol ; 536(Pt 1): 101-10, 2001 Oct 01.
Artigo em Inglês | MEDLINE | ID: mdl-11579160

RESUMO

1. Nicotinic effects on glycine release were investigated in slices of lumbar spinal cord using conventional whole-cell recordings. In most of the substantia gelatinosa (SG) neurons tested, nicotine increased the frequency of the glycinergic spontaneous miniature inhibitory postsynaptic currents (mIPSCs). In a smaller proportion, nicotine evoked not only this same presynaptic response but also a postsynaptic response. 2. Nicotinic facilitation of glycinergic mIPSCs was investigated in mechanically dissociated SG neurons using nystatin-perforated patch recordings. Nicotine (3 x 10(-6) to 10(-5) M) reversibly enhanced the frequency of glycinergic mIPSCs without altering their amplitudes, thus indicating that nicotine facilitates glycine release through a presynaptic mechanism. 3. Choline, a selective alpha7 subunit of nicotinic acetylcholine receptor (nAChR) agonist, had no effect on the mIPSC frequency while anatoxin A, a broad-spectrum agonist of nAChR, facilitated the mIPSC frequency. 4. alpha-Bungarotoxin, a selective alpha7 subunit antagonist, failed to block the nicotinic facilitatory action. Mecamylamine, a broad-spectrum nicotinic antagonist, reversibly inhibited nicotinic action. Dihydro-beta-erythroidine, a selective antagonist of nAChRs containing alpha4-beta2 subunits, completely blocked nicotinic action. 5. Ca(2+)-free but not Cd(2+)-containing bath solutions blocked nicotinic actions. 6. We therefore conclude that nicotine facilitates glycine release in the substantia gelatinosa of the spinal dorsal horn via specific nAChRs containing alpha4-beta2 subunits. This action on a subset of presynaptic nAChRs may underlie nicotine's modulation of noxious signal transmission and provide a cellular mechanism for the analgesic function of nicotine.


Assuntos
Glicina/metabolismo , Nicotina/farmacologia , Agonistas Nicotínicos/farmacologia , Substância Gelatinosa/metabolismo , Valina/análogos & derivados , 6-Ciano-7-nitroquinoxalina-2,3-diona/farmacologia , Anestésicos Locais/farmacologia , Animais , Toxinas Bacterianas/farmacologia , Bicuculina/farmacologia , Bungarotoxinas/farmacologia , Cálcio/metabolismo , Canais de Cálcio/metabolismo , Colina/farmacologia , Toxinas de Cianobactérias , Di-Hidro-beta-Eritroidina/farmacologia , Antagonistas de Aminoácidos Excitatórios/farmacologia , Antagonistas GABAérgicos/farmacologia , Toxinas Marinhas/farmacologia , Mecamilamina/farmacologia , Microcistinas , Terminações Nervosas/metabolismo , Inibição Neural/efeitos dos fármacos , Inibição Neural/fisiologia , Antagonistas Nicotínicos/farmacologia , Nootrópicos/farmacologia , Técnicas de Cultura de Órgãos , Técnicas de Patch-Clamp , Ratos , Ratos Wistar , Receptores Nicotínicos/metabolismo , Substância Gelatinosa/citologia , Substância Gelatinosa/efeitos dos fármacos , Tetrodotoxina/farmacologia , Tropanos , Valina/farmacologia , Receptor Nicotínico de Acetilcolina alfa7 , Ácido gama-Aminobutírico/metabolismo
5.
J Neurosci ; 21(9): 2983-91, 2001 May 01.
Artigo em Inglês | MEDLINE | ID: mdl-11312282

RESUMO

Glycine release was facilitated by the activation of presynaptic ATP receptors (P(2X)-type) in a preparation of dissociated trigeminal nucleus pars caudalis neurons in which the native synaptic boutons were preserved. The action of ATP was completely blocked by substance P (SP) without alteration of the miniature IPSC (mIPSC) amplitude distribution. SP itself had no effect on mIPSC frequency or amplitude. The inhibitory effect of SP on ATP action was blocked by CP99994, indicating that the SP receptors are of the neurokinin-1 type. The ATP-induced facilitation of the mIPSC frequency was unaffected by Cd(2+). Moreover, SP did not inhibit the increase in mIPSC frequency induced high K(+) application, suggesting that SP did not modulate voltage-dependent calcium channels or subsequent steps in the release process. KT5720 and phorbol 12-myristate 13-acetate did not block SP action, indicating that neither the cAMP-protein kinase A nor the protein kinase C pathway mediates the SP effects. However, in the presence of N-(6-aminohexyl)-5-chloro-1-naphthalene sulphonamide (W-7), SP was no longer able to inhibit the ATP-induced stimulation of mIPSC frequency. 1-[N,O-bis(5-isoquinolinesulfonyl)-N-methyl-l-tyrosyl]-4-phenylpiperazine also suppressed the SP action, suggesting that SP modulates P(2X) receptors via a Ca(2+)/calmodulin-dependent protein kinase II-mediated pathway. In conventional whole-cell mode, the presence of W-7 in the patch pipette did not affect the SP inhibitory action. Thus, SP is not likely to be generating its modulation through the production of a retrograde signal (involving calmodulin) from the postsynaptic cell to the presynaptic boutons. These results are the first demonstration of the modulation of one presynaptic receptor by another. Because SP inhibits the ATP stimulation of glycine release, SP may play a significant role in hyperalgesia or chronic pain.


Assuntos
Trifosfato de Adenosina/metabolismo , Glicina/metabolismo , Neurônios/metabolismo , Substância P/metabolismo , Núcleo Inferior Caudal do Nervo Trigêmeo/metabolismo , Trifosfato de Adenosina/antagonistas & inibidores , Trifosfato de Adenosina/farmacologia , Animais , Cádmio/farmacologia , Separação Celular/métodos , Proteínas Quinases Dependentes de AMP Cíclico/metabolismo , Inibidores Enzimáticos/farmacologia , Técnicas In Vitro , Inibição Neural/efeitos dos fármacos , Inibição Neural/fisiologia , Antagonistas dos Receptores de Neurocinina-1 , Neurônios/citologia , Neurônios/efeitos dos fármacos , Técnicas de Patch-Clamp , Potássio/metabolismo , Potássio/farmacologia , Terminações Pré-Sinápticas/metabolismo , Proteína Quinase C/metabolismo , Ratos , Ratos Wistar , Receptores Purinérgicos P2/metabolismo , Medula Espinal/citologia , Medula Espinal/efeitos dos fármacos , Medula Espinal/metabolismo , Substância P/farmacologia , Núcleo Inferior Caudal do Nervo Trigêmeo/citologia , Núcleo Inferior Caudal do Nervo Trigêmeo/efeitos dos fármacos
6.
J Neurophysiol ; 85(1): 332-40, 2001 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-11152733

RESUMO

Spontaneous miniature glycinergic inhibitory postsynaptic currents (mIPSCs) in mechanically dissociated rat sacral dorsal commissural nucleus (SDCN) neurons attached with intact glycinergic presynaptic nerve terminals and evoked IPSCs (eIPSCs) in the slice preparation were investigated using nystatin-perforated patch and conventional whole cell recording modes under the voltage-clamp conditions. Trans-ACPD (tACPD) reversibly reduced the mIPSC frequency without affecting the mean amplitude. The effect was mimicked by a specific metabotropic glutamate receptor (mGluR) II subtype agonist, (2S, 1'S, 2'S)-2-(carboxycyclo propyl) glycine (L-CCG-I), and a specific mGluRIII subtype agonist, 2-amino-4-phosphonobutyrate (L-AP4). These inhibitory effects on mIPSC frequency were blocked by the specific antagonists for mGluRII, alpha-methyl-1-(2S, 1'S, 2'S)-2-(carboxycyclo propyl) glycine and (RS)-alpha-cyclopropyl-4-phosphonophenylglycine. In the slice preparation, eIPSC amplitude and mIPSC frequency were decreased reversibly by L-CCG-I (10(-6) M) and L-AP4 (10(-6) M). In K(+)-free or K(+)-free external solution with Ba(2+) and Cs(+), Ca(2+)-free or Cd(2+) external solution, the inhibitory effect of tACPD on mIPSC frequency was unaltered. Forskolin and 8-Br-cAMP significantly increased presynaptic glycine release, and prevented the inhibitory action of tACPD on mIPSC frequency. Sp-cAMP, however, did not prevent the inhibitory action of tACPD on mIPSC frequency. It was concluded that the activation of mGluRs inhibits glycine release by reducing the action of cAMP/PKA pathway.


Assuntos
AMP Cíclico/metabolismo , Cicloleucina/análogos & derivados , Neurônios/metabolismo , Terminações Pré-Sinápticas/metabolismo , Receptores de Glicina/metabolismo , Medula Espinal/metabolismo , 8-Bromo Monofosfato de Adenosina Cíclica/farmacologia , Aminoácidos Dicarboxílicos , Aminobutiratos/farmacologia , Animais , Bário/farmacologia , Cádmio/farmacologia , Cálcio/metabolismo , Colforsina/farmacologia , AMP Cíclico/farmacologia , Cicloleucina/farmacologia , Potenciais Evocados/efeitos dos fármacos , Potenciais Evocados/fisiologia , Agonistas de Aminoácidos Excitatórios/farmacologia , Técnicas In Vitro , Inibição Neural/efeitos dos fármacos , Inibição Neural/fisiologia , Neurônios/citologia , Neurônios/efeitos dos fármacos , Técnicas de Patch-Clamp , Potássio/metabolismo , Terminações Pré-Sinápticas/efeitos dos fármacos , Propionatos , Ratos , Ratos Wistar , Receptores de Glutamato Metabotrópico/agonistas , Medula Espinal/citologia , Medula Espinal/efeitos dos fármacos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...